PBH — Prestige Consumer Healthcare Inc.

—
NYSE · Health Care · Pharmaceuticals · CIK 1295947 ·
Last close
$48.22
Market Cap
$2.29B
52W High
$71.07
52W Low
$41.77
ADV30
595,145
Next earnings
2027-02-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 336,307,000 172,538,000 80,712,000 25,295,000 4,721,661,000 46,515,000 2,776,996,000
Jun 2026 265,710,000 136,188,000 52,520,000 29,177,000 4,568,573,000 89,127,000 2,651,857,000
Mar 2026 281,617,000 146,299,000 75,492,000 53,928,000 3,494,313,000 63,868,000 1,606,797,000
Dec 2025 283,444,000 157,369,000 82,491,000 46,696,000 3,494,743,000 62,373,000 1,665,292,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$229,781,000
Investing CF
$-1,334,615,000
Financing CF
$1,031,920,000
CapEx
$-15,565,000
Dividends Paid
—
Buybacks
$-46,508,000
EPS Diluted TTM
$3.24
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$1,800,575,000
Inventory
$179,203,000
Receivables
$244,124,000
ST Investments
—
EBIT TTM
$278,648,000
Pretax Income TTM
$212,577,000
Interest Exp TTM
$66,071,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,167,078,016
EBITDA
$345,083,008
Free Cash Flow
$147,570,368
Enterprise Value
$4,117,855,488
Total Cash
$46,515,000
Total Debt
$2,127,243,008
Shares Out
47,397,106
Trailing EPS
$3.24
Book Value
$41.03
ROE
8.2%
ROA
4.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 1,088,705,000 309,409,000 190,301,000 3,494,313,000 1,606,797,000 1,887,516,000 257,627,000
Mar 2025 1,137,762,000 349,241,000 214,605,000 3,402,218,000 1,567,321,000 1,834,897,000 251,515,000
Mar 2024 1,125,357,000 342,429,000 209,339,000 3,318,417,000 1,663,333,000 1,655,084,000 248,926,000
Mar 2023 1,127,725,000 347,802,000 -82,306,000 3,353,729,000 1,906,645,000 1,447,084,000 229,716,000

TTM Snapshot

Revenues TTM
$1,104,885,000
NetIncome TTM
$172,012,000
OpCashFlow TTM
—
Assets (Latest)
$4,568,573,000
Forward EPS
$5.10

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $45.00 · spot: $50.62 · call volume: 2 · put volume: 40

Peers — same industry

TickerNameMarket CapLastDaily %
GLPGF Lakefront Biotherapeutics NV $2.30B $35.15 —
PHVS Pharvaris N.V. $2.27B $32.28 —
LKFT Lakefront Biotherapeutics NV $2.25B $34.39 —
NAMS NewAmsterdam Pharma Co N.V. $2.33B $19.39 —
GRFS Grifols SA $2.23B $8.63 —

News headlines (Yahoo Finance, 1h cache)

Prestige Consumer Healthcare (PBH) Stock May Be Undervalued Despite Lowered Revenue Guidance
2026-11-16 23:24 · Yahoo
Prestige Consumer Healthcare Q2 Earnings Call Highlights
2026-11-08 03:14 · Yahoo
Prestige Consumer Healthcare (PBH) Stock Dropped, So What Is Driving Attention Now?
2026-11-06 15:15 · Yahoo
Prestige Consumer Healthcare Inc (PBH) (Q2 2027) Earnings Call Highlights: Revenue Surges 23% ...
2026-11-06 09:11 · Yahoo
Prestige Consumer Healthcare Stock In Focus After Revenue Rose But Profit Fell
2026-11-05 14:18 · Yahoo
Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key Metrics
2026-11-05 13:30 · Yahoo
Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates
2026-11-05 11:35 · Yahoo
Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot
2026-11-05 11:16 · Yahoo
Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results
2026-11-05 11:00 · Yahoo
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
2026-10-15 13:23 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.